Biotech company Moderna will ask for an emergency use authorization from the Food and Drug Administration for its covid-19 vaccine on Monday, according to a new press release posted to the firm’s website. Moderna also released new information indicating its messenger RNA-based vaccine has a 94.1% efficacy rate in a…
from Gizmodo https://ift.tt/3ocnpO2
